Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 May 1;53(3):115-121.
doi: 10.15586/aei.v53i3.1277. eCollection 2025.

Corticosteroid prescription in children with respiratory symptoms: A real-life study

Affiliations
Observational Study

Corticosteroid prescription in children with respiratory symptoms: A real-life study

Remedios Cárdenas Contreras et al. Allergol Immunopathol (Madr). .

Abstract

Asthma is one of the most common childhood diseases. Most children respond to low doses of corticosteroids and/or anti-leukotrienes. However, a small percentage remain symptomatic. They require high doses of inhaled corticosteroids (ICS) and anti-leukotrienes, sometimes with long-acting bronchodilators (LABA) and occasionally systemic corticosteroids (SC). However, we frequently observe that the only treatment they receive for exacerbations is short-acting beta-agonists (SABA) and oral corticosteroids (OC) without adding ICS as a maintenance treatment to prevent new episodes. This leads to frequent exacerbations, airflow limitation, and significant alterations in the quality of life. In addition, this results in high resource consumption, frequent emergency room visits, and school absenteeism, leading to absence from work for caregivers. A descriptive, retrospective, observational, and multicenter study was carried out on patients under 12 years of age, who attended pediatric allergy consultations for the first time. The main objective was to determine the consumption of SCs because of respiratory exacerbations in the year before the first consultation. Data were obtained from 144 children, 58.3% male, with a median age of 5 years. It was found that during the year before attending our clinic, 70% had perennial symptoms and were only prescribed with salbutamol on demand when they presented with respiratory symptoms. They had not been prescribed with ICS or anti-leukotrienes. They required attention in the emergency room of their nearest health center or hospital on an average of three times per year. During these exacerbations, almost 75% received SCs(prednisolone), with an average of 2.6 annual cycles (0-12) prescribed in more than half of the cases in the emergency room. In over 80% of the cases, the effects of SC abuse were not previously monitored. The overuse of SC in atopic children with respiratory symptoms was confirmed in our group, which requires considering behavioral changes.

Keywords: asthma; children; corticosteroid overuse.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. 1. The Global Asthma Report 2014. http://www.theunion.org/whatwe-do/publications/technical/english/Global_....
    1. 2. World Health Organization. Global surveillance, prevention and control of chronic respiratory diseases.
    1. 3. Carvajal-Urueña I, García-Marcos L, Busquets-Monge R, et al. Variaciones geográficas en la prevalencia de síntomas de asma en los niños y adolescentes españoles. International Study of Asthma and Allergies in Childhood (ISAAC) fase III España [Geographic variation in the prevalence of asthma symptoms in Spanish children and adolescents. International Study of Asthma and Allergies in Childhood (ISAAC) Phase 3, Spain]. Arch Bronconeumol. 2005;41(12):659–666. 10.1016/S1579-2129(06)60333-9 - DOI
    1. 4. Guía GEMA 5.4. www.semg.es/index.php/consensos-guias-y-protocolos/427-gema-5-4-guia-esp....
    1. 5. Bercedo-Sanz A, Martínez-Torres A, González-Díaz C, López-Silvarrey Varela A, Pellegrini-Belinchón FJ, Aguinaga-Ontoso I, et al. Prevalence and temporal evolution of asthma symptoms in Spain. Global Asthma Network (GAN) study. An Pediatr. 2022;97:161–7. 10.1016/j.anpede.2021.10.005 - DOI

Publication types

Substances